Hualan Biological Bacterin Inc.

Total Valuation

Hualan Biological Bacterin Inc. carries a market capitalization of 9.85B, placing it among publicly traded companies globally. Its enterprise value stands at 8.01B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Hualan Biological Bacterin Inc. currently has 601.03M shares outstanding.

Valuation Ratios

Hualan Biological Bacterin Inc. trades at a trailing price-to-earnings ratio of 49.89. The price-to-sales ratio is 8.70, and the price-to-book ratio stands at 3.59.

Enterprise Valuation

On an enterprise value basis, Hualan Biological Bacterin Inc. trades at an EV/EBITDA multiple of 49.37 and an EV/FCF ratio of 243.30. The EV/Sales ratio of 6.95 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 49.37 provides insight into valuation relative to core operating earnings.

Financial Position

Hualan Biological Bacterin Inc. maintains a current ratio of 4.71, meaning it holds 4.7x the short-term assets needed to cover near-term liabilities.

Financial Efficiency

Taxes

Over the trailing twelve months, Hualan Biological Bacterin Inc. has paid -448,480.26 in income taxes, reflecting an effective tax rate of 21.02.

Stock Price Statistics

Hualan Biological Bacterin Inc.'s stock has declined approximately -1.36986% over the past 52 weeks. The 50-day moving average sits at 18.29, while the 200-day moving average is 19.81.

Income Statement

Over the trailing twelve months, Hualan Biological Bacterin Inc. generated 1.15B in revenue and converted that into 201.04M in net income, yielding earnings per share of 0.34. EBITDA reached 162.19M, while operating income came in at 162.19M.

Balance Sheet

Total book value stands at 2.80B, with working capital of 3.52B providing operational flexibility.

Cash Flow

After subtracting -27.12M in capital expenditures, free cash flow totaled -27.12M - equivalent to -0.05 per share.

Margins

Hualan Biological Bacterin Inc. operates with a gross margin of 81.02, reflecting its pricing power and cost economics. The operating margin of 14.08 and net profit margin of 17.45 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 29.30 indicates the proportion of earnings distributed to shareholders.

Stock Splits

Hualan Biological Bacterin Inc.'s most recent stock split took place on June 7, 2023 with a 2:3 split ratio.

Scores

Hualan Biological Bacterin Inc. posts an Altman Z-Score of 7.36, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.